Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 6Fatigue 6Breast Neoplasms 5Anxiety Disorders 3Psychological Well-Being 2Pain 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Depression 2Caregiver Burden 2Uterine Neoplasms 1Tuberous Sclerosis 1Substance-Related Disorders 1Smoking Cessation 1Sleep Wake Disorders 1Sleep Initiation and Maintenance Disorders 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pain, Postoperative 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neoplasm Regression, Spontaneous 1Multiple Myeloma 1Malignant Hepatobiliary Neoplasm 1Lymphoma 1Leukemia 1Hematopoietic Cell Transplantation Recipient 1Head and Neck Neoplasms 1

Interventions

ponatinib 1Telemedicine 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Malignant Hepatobiliary Neoplasm × Acceptance and Commitment Therapy × Clear all
NCT07124546 2025-08-15

Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers

Mayo Clinic

Phase NA Recruiting
60 enrolled
Gastrointestinal

Malignant Hepatobiliary Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡